Loading...
Loading...
Gainers
- Adverum Biotechnologies ADVM shares are trading higher after the company announced "positive" interim data from Cohorts 1-4 of the OPTIC Phase 1 clinical trial of ADVM-022 intravitreal inject gene therapy.
- CymaBay Therapeutics CBAY shares are trading lower after the company issued Q2 earnings results. It also noted it stopped its review of strategic options and plans to focus on reinstating the clinical development program for seladelpar in PBC.
- CarParts.com PRTS shares are trading higher after the company reported Q2 EPS of $0.03, up from $(0.04) and better-than-expected Q2 sales results.
- Extended Stay America STAY shares are trading higher after the company reported better-than-expected Q2 sales results.
- Nautilus NLS shares are trading higher after the company reported Q2 sales results were higher year-over-year.
Losers
- Inovio Pharmaceuticals INO shares are trading lower after the company reported worse-than-expected Q2 EPS and sales results.
- Occidental Petroleum OXY shares are trading lower after the company reported worse-than-expected Q2 EPS results.
- Sunrun RUN shares are trading lower after the company reported worse-than-expected Q2 sales results.
- Ideanomics IDEX shares are trading lower after the company reported Q2 EPS and sales results were down year over year.
- IAC/InterActiveCorp IAC shares are trading lower after the company reported Q2 GAAP EPS of $(1.13) vs $0.16 in the same quarter last year and sales of $726.4 million, compared to $1.19 billion year over year.
- ANGI Homeservices ANGI shares are trading lower in sympathy with its parent company, IAC, after it released weak Q2 earnings results.
- Hertz HTZ shares are trading lower after the company reported Q2 EPS and sales results were down year over year.
- Tilray TLRY shares are trading lower after the company reported worse-than-expected Q2 EPS and sales results.
- ZoomInfo Technologies ZI shares are trading lower despite the company reporting better-than-expected Q2 EPS and sales results.
- Catalyst Pharmaceuticals CPRX shares are trading lower after the company reported Q2 earnings results.
Loading...
Loading...
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
We simplify the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in